ロード中...
Response of Degarelix treatment in human prostate cancer monitored by HR-MAS (1)H NMR spectroscopy
INTRODUCTION: The androgen receptor (AR) is the master regulator of prostate cancer cell metabolism. Degarelix is a novel gonadotrophin-releasing hormone blocker, used to decrease serum androgen levels in order to treat advanced human prostate cancer. Little is known of the rapid metabolic response...
保存先:
| 出版年: | Metabolomics |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927592/ https://ncbi.nlm.nih.gov/pubmed/27429605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1055-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|